1. The metabolic syndrome and type 2 diabetes: What has gone wrong in type 2 diabetes care?

   • Werner K. Waldhäusl

   Invited Commentary Pages: 395 - 396

2. Web alert

   News Pages: 397 - 398

3. Literatuer alert

   Abstract Pages: 399 - 400

4. Clinical trials report

   • Andrew J. M. Boulton

   BriefCommunication Pages: 403 - 404

5. Aldose reductase inhibition in the treatment of diabetic neuropathy: Where are we in 2004?

   • Kenneth H. Gabbay

   OriginalPaper Pages: 405 - 408

6. Chronic inflammatory demyelinating polyradiculoneuropathy in diabetes mellitus

   • D. Ram Ayyar
   • Khema R. Sharma

   OriginalPaper Pages: 409 - 412

7. Reducing the incidence of foot ulceration and amputation in diabetes

   • Cynthia L. Bartus
   • David J. Margolis

   OriginalPaper Pages: 413 - 418

8. Research development in the pathogenesis of neuropathic diabetic foot ulceration

   • Alberto Piaggesi

   OriginalPaper Pages: 419 - 423

9. Is this bone infected or not? Differentiating neuro-osteoarthropathy from osteomyelitis in the diabetic foot

   • Anthony R. Berendt
   • Benjamin Lipsky

   OriginalPaper Pages: 424 - 429

10. Intensive treatment of diabetic nephropathy

    • Robert Stanton

    Clinical Trials Report Pages: 433 - 434

11. Use of genetic mouse models in the study of diabetic nephropathy

    • Terri J. Allen
    • Mark E. Cooper
    • Hui Y. Lan

    OriginalPaper Pages: 435 - 440

12. Clinical studies of advanced glycation end product inhibitors and diabetic kidney disease

    • Mark E. Williams

    OriginalPaper Pages: 441 - 446

13. Transforming growth factor-beta: A clinical target for the treatment of diabetic nephropathy

    • Tracy A. McGowan
    • Yanqing Zhu
    • Kumar Sharma

    OriginalPaper Pages: 447 - 454

14. Diabetic nephropathy in African-American patients

    • Errol D. Crook
    • Sejal R. Patel

    OriginalPaper Pages: 455 - 461

15. Gene expression in diabetic nephropathy

    • Daniela Hohenadel
    • Fokko J. van der Woude

    OriginalPaper Pages: 462 - 469